MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4103/ijp.ijp_1224_25

Медицинская библиотека · Indian journal of pharmacology · 2026

Hepatic adverse effects of valproic acid: Management strategies.

Bouaziz Imen, Atheymen Rim, Sahnoun Rym, Ksouda Kamilia, Affes Hanen, Hammami Serria, Zghal Khaled

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Valproic acid (VPA) is a widely prescribed first-generation antiepileptic drug. It can induce different liver adverse effects (AEs) which range from mild to severe.

MATERIALS AND

METHODS

A retrospective study was conducted by collecting 9-year reports (from January 2015 to June 2023) of VPA-associated hepatic AEs. It was collected in the Regional Center of Pharmacovigilance of Sfax (Tunisia). Causality was evaluated with the French Bégaud et al. imputability method. Plasma VPA concentrations were measured using an automated enzyme immunoassay (INDIKO).

RESULTS

We collected the eight cases of hepatic cytolysis with varying severity: Six had mild elevations of liver enzymes, one presented with moderately severe cytolysis and one case was fatal. There management strategies were guided by both transaminase levels and VPA concentrations. For those with alanine aminotransferase levels ≥5 times the upper limit of normal (ULN), we conducted the drug discontinuation. However, for patients with lower levels of transaminases, plasma VPA level measurement was recommended. The concentrations were within or near the ULN. Management consisted of either withdrawal or dose reduction, depending on associated clinical symptoms. Additional investigations to rule out nondrug-related causes performed in five cases were negatives. Most patients recovered favorable outcome after discontinuation or VPA dose reduction.

CONCLUSION

Management of VPA-induced hepatic cytolysis requires integrating the severity of liver enzyme elevations, plasma drug level measurements, and the results of etiological investigation to guide the clinical decisions.

Для цитирования: Bouaziz Imen, Atheymen Rim, Sahnoun Rym, Ksouda Kamilia, Affes Hanen, Hammami Serria, Zghal Khaled. Hepatic adverse effects of valproic acid: Management strategies.. Indian journal of pharmacology. 2026. DOI: 10.4103/ijp.ijp_1224_25.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.